Low-Density Lipoprotein Cholesterol Levels and Statin Treatment—A Moving Target?

Simon B. Ascher,Blake R. Charlton,Rita F. Redberg

JAMA INTERNAL MEDICINE（2016）

引用 5|浏览2

暂无评分

摘要

22. Dormuth CR, Filion KB, Paterson JM, et al; Canadian Network for Observational Drug Effect Studies Investigators. Higher potency statins and the risk of new diabetes: multicentre, observational study of administrative databases. BMJ. 2014;348: g3244. 23. Dormuth CR, Hemmelgarn BR, Paterson JM, et al; Canadian Network for Observational Drug Effect Studies. Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases. BMJ. 2013;346:f880.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要